Experience

Greenback Recycling Technologies

• United Kingdom
• Environmental Services
• 1 - 100 Employee

• Chair

  • Dec 2021 - Present

  Greenback is transforming the broken plastics recycling system by creating a market for the $100bn of plastic wasted each year which causes huge damage to oceans, wildlife, landscapes, climates and people. Greenback is transforming the broken plastics recycling system by creating a market for the $100bn of plastic wasted each year which causes huge damage to oceans, wildlife, landscapes, climates and people.



QinetiQ

• United Kingdom
• Defense and Space Manufacturing
• 700 & Above Employee

• Non Executive Director

  • Mar 2014 - Present

  Experts in defence, aerospace and security. A FTSE 250 company employing more than 9000 people worldwide offering high-end knowledge underpinned by world-class research and innovation. QinetiQ uses its domain knowledge to provide technical support, training, test and evaluation, and know-how to customers in the global aerospace, defence and security markets. Customers include government organisations, such as the UK MOD and the US DOD, and a range of other government and commercial customers globally.



Benchmark Holdings plc

• Non Executive Director

  • Dec 2013 - Present

  Founded in 2000, Benchmark Holdings plc is an established international animal health, technical publishing and sustainability business. Its activities include the development, manufacture and commercialisation of animal health vaccines, medicines, biocides and diagnostics, with a key focus on aquaculture. The Group also provides consultancy services, scientific and technical information to industry participants across the food chain. Clients include blue-chip multinationals such as McDonald's, M&S, Bayer and Novartis, and indicate Benchmark's world-leading status in the sustainability space.



Schroder UK Public Private Trust plc (SUPP)

• Non Exec Chair

  • Mar 2015 - Jun 2021



Horizon Discovery Group plc

• Non Executive Director

  • Jun 2014 - Jan 2021

  Horizon Discovery is a UK Biotechnology company that combines a long scientific heritage in translational research with GENESIS(tm), a precision gene-editing platform that incorporates rAAV, CRISPR and ZFN technologies. The company supplies genetically-defined cell lines, gene-editing tools and services, custom cell line generation, reporter gene assay kits, molecular reference standards and assay development and screening services to over 1,000 organisations engaged in academic research; drug discovery and development; clinical diagnostics; and biopharmaceutical process optimization. Horizon aspires to provide science-driven research solutions that lead to the advancement in the understanding of the genetic basis of disease and better outcomes for patients. Horizon was bought by Perkin Elmer.



Mercia Asset Management PLC

• United Kingdom
• Investment Management
• 1 - 100 Employee

• Non Exec Chair

  • Dec 2014 - Jun 2019

  Mercia Technologies is one of the leading investment businesses in UK technology, specialising in the commercialisation of pioneering businesses across exciting growth sectors in which deep expertise is held. Mercia’s vision is to become a leading national player in the creation, funding, incubation and development of high-growth technology businesses with an emphasis in the Midlands and the North of the UK. Mercia brings together technology transfer, company formation and incubation, commercialisation and investment, to technology ventures. Mercia is focused on creating and developing companies which combine technology and service provision, are rich in intellectual property, are scalable and require relatively modest capital infusion. Mercia focuses on some of the highest growth sectors in the UK, leveraging deep expertise across a number of arenas - including digital, electronics and hardware, advanced materials, engineering and specialised manufacturing and life sciences.



PTT Global Chemical Public Company Limited

• International Advisory Board

  • Jan 2014 - Sep 2016

  Strategic Advisory Board - technology, innovation, ventures. Industrial and green chemicals. Strategic Advisory Board - technology, innovation, ventures. Industrial and green chemicals.



Fight for Sight

• United Kingdom
• Non-profit Organizations
• 1 - 100 Employee

• Board of Trustees

  • Mar 2013 - Mar 2016

  Fight for Sight is the only UK charity focused on funding research into blindness and eye disease. Almost 2 million people in the UK alone live with sight loss, one in every nine over 60 years old and 40,000 children. 80% of all sight loss can be prevented or cured but research funding is desperately needed. Fight for Sight is the only UK charity focused on funding research into blindness and eye disease. Almost 2 million people in the UK alone live with sight loss, one in every nine over 60 years old and 40,000 children. 80% of all sight loss can be prevented or cured but research funding is desperately needed.



Innovate UK

• United Kingdom
• Non-profit Organizations
• 400 - 500 Employee

• Advisory Board Member

  • Sep 2012 - Nov 2015

  Advisory Board for Emerging Technology program - current programs - Synthetic Biology, Energy Efficiency and Energy Efficient Computing. Advising on priority technology areas, program structure and aims. Advisory Board for Emerging Technology program - current programs - Synthetic Biology, Energy Efficiency and Energy Efficient Computing. Advising on priority technology areas, program structure and aims.



Plaxica Ltd

• Non Exec Director

  • Feb 2009 - Jul 2013

  Non Executive Investor Director Plaxica is a process technology licensing business. It develops, demonstrates and designs process plant for the production of the key intermediates for stereocomplex Polylactic acid (PLA). The Plaxica Technology (Optipure) uses a chemical process to convert a wide variety of sugars to lactic acid and lactides which can be polymerised to PLA - producing both L and D enantiomers of lactic acid/lactide. Non Executive Investor Director Plaxica is a process technology licensing business. It develops, demonstrates and designs process plant for the production of the key intermediates for stereocomplex Polylactic acid (PLA). The Plaxica Technology (Optipure) uses a chemical process to convert a wide variety of sugars to lactic acid and lactides which can be polymerised to PLA - producing both L and D enantiomers of lactic acid/lactide.



Imperial Innovations Group plc

• Chief Executive Officer

  • Jan 2002 - Jul 2013

  Technology transfer, incubation and venture investment company. Imperial Innovations is an AIM listed business having raised £206m of investment from the institutional investors. Innovations major shareholders are Invesco Perpetual (45.5%), Lansdowne (13.7%) and Imperial College (30.3%). The company builds and invests in technology companies and its focus is Cambridge, Oxford, University College and Imperial College London where it gains access to opportunities through local collaborations as well as direct networks. It invests in healthcare (therapeutics and medtech), engineering, cleantech and IT companies. Innovations investment portfolio comprises circa 30 accelerated growth companies include Circassia (allergy therapeutics), Nexeon (lithium ion battery technology) and Veryan Medical (novel vascular stent technology)



i2India

• Bangalore, India

• Director

  • Mar 2008 - Oct 2011

  Co-founded with Chris Mathias to develop and incubate healthcare, engineering and software technologies to meet emerging market needs in India. Sourcing technologies internationally and working with local research organisations and universities Co-founded with Chris Mathias to develop and incubate healthcare, engineering and software technologies to meet emerging market needs in India. Sourcing technologies internationally and working with local research organisations and universities



EvoElectric Ltd

• Non Exec Director

  • Jun 2007 - Jul 2011

  Developing and commercialising axial flux generators and motors for applications in automotive, electric vehicles and power generation. Technology provides increased efficiency, much lower weight and lower carbon emissions. In 2011 GKN invested in Evo Electric and funded the establishment of a joint venture manufacturing facility. Developing and commercialising axial flux generators and motors for applications in automotive, electric vehicles and power generation. Technology provides increased efficiency, much lower weight and lower carbon emissions. In 2011 GKN invested in Evo Electric and funded the establishment of a joint venture manufacturing facility.



Thiakis Ltd

• Non Exec Director

  • Aug 2004 - Dec 2008

  Developing novel medicines for the treatment and management of obesity and metabolic disease. £1.5m invested in 2006 alongside Novo and Advent in £10m series A round. Sold to Wyeth (now Pfizer) for cumulative up to £100m realising £3.1m with further milestones due up to £16.1m. Developing novel medicines for the treatment and management of obesity and metabolic disease. £1.5m invested in 2006 alongside Novo and Advent in £10m series A round. Sold to Wyeth (now Pfizer) for cumulative up to £100m realising £3.1m with further milestones due up to £16.1m.



Powerlase Limited

• Non Exec Director

  • 2002 - 2004

  An innovative, high power pulsed laser design and manufacturing business. I sat on the board as Investor Director whilst Imperial Innovations was a shareholder and investor. An innovative, high power pulsed laser design and manufacturing business. I sat on the board as Investor Director whilst Imperial Innovations was a shareholder and investor.



TurboPower Systems

• London, United Kingdom

• Non Exec Director

  • Jul 1997 - Jun 2000

  Turbo was spun out of the Mechanical Engineering dept of Imperial College and listed on the main market - founded by Colin Besant and colleagues. It develops and manufactures innovative electric motors, generators and power electronics for applications in industries such as automotive,industrial, transport, power and defense Turbo was spun out of the Mechanical Engineering dept of Imperial College and listed on the main market - founded by Colin Besant and colleagues. It develops and manufactures innovative electric motors, generators and power electronics for applications in industries such as automotive,industrial, transport, power and defense



The Signet Group plc

• Head of Gold Import/Buying

  • Sep 1991 - Aug 1994

  Responsible for trading gold and for manufacturing joint venture based in Italy, sourcing gold jewellery and quality controlling it for the group. Logistics management and restructuring in the UK and overall responsibility for buying gold chains, bracelets and bangles. Responsible for trading gold and for manufacturing joint venture based in Italy, sourcing gold jewellery and quality controlling it for the group. Logistics management and restructuring in the UK and overall responsibility for buying gold chains, bracelets and bangles.



Scotiabank

• Canada
• Banking
• 700 & Above Employee

• Marketing Manager, Precious Metals

  • 1988 - 1990

  Responsible for building a precious metals lending and trading business with customers ranging across industrial, mining and jewellery manufacture. Key markets: UK, Germany and Italy. Responsible for building a precious metals lending and trading business with customers ranging across industrial, mining and jewellery manufacture. Key markets: UK, Germany and Italy.



Shell Chemicals International

• Business Manager

  • 1988 - 1989

  Responsible for buying a range of chemicals used in the manufacture and sale of polypropylene, polystyrene, polyethylene and other polymers. Development of the market and sales channels for Shell polymers including working on the launch of new products. Responsible for buying a range of chemicals used in the manufacture and sale of polypropylene, polystyrene, polyethylene and other polymers. Development of the market and sales channels for Shell polymers including working on the launch of new products.



Shell

• United Kingdom
• Oil and Gas
• 700 & Above Employee

• Product Manager

  • 1985 - 1988

  Management of product sales and manufacturing requirement for polystyrene and a range of other polymers. Management of product sales and manufacturing requirement for polystyrene and a range of other polymers.